Breaking News Instant updates and real-time market news.

USB

U.S. Bancorp

$51.60

0.38 (0.74%)

, WFC

Wells Fargo

$54.31

-0.31 (-0.57%)

12:40
01/11/17
01/11
12:40
01/11/17
12:40

Mortgage lenders faced headwind in Q4, WSJ says

According to Mortgage Bankers Association data, in the last three months of 2016, mortgage applications dropped 21% from the third quarter, led by demand for refinances which fell 31%, says the Wall Street Journal. Interest rates jumped by more than half a percentage point following Donald Trump's election, according to the WSJ. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

USB

U.S. Bancorp

$51.60

0.38 (0.74%)

WFC

Wells Fargo

$54.31

-0.31 (-0.57%)

MS

Morgan Stanley

$43.24

0.18 (0.42%)

BAC

Bank of America

$22.87

-0.07 (-0.31%)

GS

Goldman Sachs

$244.17

1.6 (0.66%)

C

Citi

$59.75

-0.485 (-0.81%)

JPM

JPMorgan

$86.55

0.12 (0.14%)

  • 12

    Jan

  • 13

    Jan

  • 13

    Jan

  • 13

    Jan

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 26

    Jan

  • 16

    Feb

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

USB U.S. Bancorp
$51.60

0.38 (0.74%)

01/11/17
UBSW
01/11/17
INITIATION
Target $60
UBSW
Buy
U.S. Bancorp initiated with a Buy at UBS
UBS analyst Saul Martinez started U.S. Bancorp with a Buy rating and $60 price target. The analyst calls the company his top pick in the Americas Banks sector.
12/05/16
BARD
12/05/16
NO CHANGE
BARD
Baird suggests booking banking stock gains at current levels
Baird is telling investors to book banking stock gains at current levels as the shares are already discounting significant fundamental improvement in 2017 and 2018. The firm has raised estimates on its banking coverage to reflect benefits from rate increases and sees slight upside if corporate tax rates are lowered, but they remain skeptical the economy can absorb significant Fed tightening without slowing.
12/21/16
ATLE
12/21/16
DOWNGRADE
ATLE
Neutral
U.S. Bancorp downgraded to Neutral from Overweight at Atlantic Equities
12/21/16
12/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Stifel with analyst Astrachan citing "recent negative FX movement, moderate anticipated input cost inflation, and continued heightened geopolitical uncertainty." 2. JetBlue (JBLU) downgraded to Market Perform from Outperform at Raymond James with analyst Savanthi Syth saying shares will be range bound near-term due to RASM pressures from capacity growth new market expansion, and increased cost inflation. 3. Barrick Gold (ABX) downgraded to Hold from Buy at TD Securities analyst Greg Barnes saying shares have significantly outperformed in 2016 and sees fewer company-specific catalysts in 2017. 4. New York Community Bancorp (NYCB) and Astoria Financial (AF) were downgraded to Underperform at FBR Capital. 5. Goldman Sachs (GS) and U.S. Bancorp (USB) were downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFC Wells Fargo
$54.31

-0.31 (-0.57%)

01/03/17
BARD
01/03/17
NO CHANGE
Target $58
BARD
Outperform
Wells Fargo a favorite bank to buy on weakness at Baird
Baird analyst David George believes the risk/reward for the banks is not attractive, as he thinks the increase in interest rates is already discounted into banking shares as investor sentiment is pervasively bullish, which has resulted in a poor setup for the banks heading into 2017. However, he would be a buyer of Wells Fargo on any weakness. George maintained his Outperform rating and $58 price target on Wells Fargo shares.
12/12/16
OPCO
12/12/16
NO CHANGE
OPCO
Outperform
Opco says 'let the bet ride' on bank stocks, ups price targets
Oppenheimer analyst Chris Kotowski says that while "one cannot remain as bullish on the group as when the stocks were cheap," investors should "let the bet ride" on bank stocks. The analyst maintains a "somewhat overweight stance" on the space, but points out the shares are getting more fully valued. Kotowski's favorite names remain Bank of America (BAC), Citi (C), CIT Group (CIT) and Goldman Sachs (GS). He raised his price target for Bank of America to $25 from $19, for Citi to $72 from $65 and for Goldman to $252 from $228.
12/14/16
JPMS
12/14/16
NO CHANGE
JPMS
Neutral
JPMorgan views Wells Fargo's Resolution Plan failure as significant
The failure of Wells Fargo's Resolution Plan is a "significant" issue with the potential for "material" consequences if Wells does not pass the next submission in March 2017, JPMorgan analyst Vivek Juneja tells investors in a research note. This adds to other issues that surfaced this week for Wells, including Prudential Financial no longer distributing insurance policies through Wells and FINRA opening up a hotline for the bank's brokers who were fired to report issues related to improper termination, the analyst contends. Juneja believes the issues add to Wells' reputational challenges and will likely pressure earnings by increasing expenses. He keeps a Neutral rating on the shares.
01/10/17
SBSH
01/10/17
DOWNGRADE
Target $225
SBSH
Sell
Goldman Sachs downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Goldman Sachs (GS) to Sell with a $225 price target, representing 6% downside from current levels. While higher interest rates benefit fixed income trading, the path is "relatively uncertain and the bar is relatively high" for Goldman, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally. Horowitz this morning also downgraded Comerica (CMA) to Sell while keeping Buy ratings on Wells Fargo (WFC) and Bank of America (BAC).
MS Morgan Stanley
$43.24

0.18 (0.42%)

01/11/17
SOCG
01/11/17
UPGRADE
SOCG
Buy
Morgan Stanley upgraded to Buy from Hold at Societe Generale
12/21/16
12/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sunoco (SUN) upgraded to Outperform from Neutral at Credit Suisse with analyst John Edwards saying valuation is "underappreciated" and said a dividend cut is unlikely given options available for Sunoco and Energy Transfer Equity (ETE) to execute before reducing payouts. 2. BP (BP) and Statoil (STO) were upgraded to Buy from Neutral at UBS. 3. Citi (C) and Bank of America (BAC) were upgraded to Overweight from Neutral at Atlantic Equities while Morgan Stanley (MS) was upgraded to Neutral from Underweight. 4. Air Products (APD) upgraded to Buy from Neutral at Monness Crespi with the firm saying it thinks that Air Products will benefit from consolidation in the industry. It says that Air Products' balance sheet will enable it to "easily bid on and win new projects" and exploit divestitures in the sector. 5. Monster Beverage (MNST) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy calling the stock his top large cap growth pick in Consumer Products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/21/16
ATLE
12/21/16
UPGRADE
ATLE
Neutral
Morgan Stanley upgraded to Neutral from Underweight at Atlantic Equities
BAC Bank of America
$22.87

-0.07 (-0.31%)

01/09/17
WELS
01/09/17
NO CHANGE
WELS
Bank of America added to Priority Stock List at Wells Fargo
Wells Fargo added Bank of America to its Priority Stock List and identifies it as its top pick among large cap banks. The firm has "growing confidence" that the bank can benefit from multiple catalysts, including higher rates, prudent balance sheet growth, capital market improvement, and cost reductions.
01/11/17
UBSW
01/11/17
DOWNGRADE
Target $23
UBSW
Neutral
Bank of America downgraded to Neutral from Buy at UBS
UBS analyst Saul Martinez downgraded Bank of America after assuming coverage of the name. The analyst views the valuation as full following the stock's outperformance since interest rates troughed in mid- 2016. He lowered his price target for the shares to $23 from $24.
01/11/17
SOCG
01/11/17
UPGRADE
SOCG
Buy
Bank of America upgraded to Buy from Hold at Societe Generale
GS Goldman Sachs
$244.17

1.6 (0.66%)

01/10/17
01/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Moody's (MCO) was downgraded to Equal Weight from Overweight at Barclays and to Neutral from Buy at UBS. 2. Goldman Sachs (GS) and Comerica (CMA) were downgraded to Sell from Neutral at Citi. 3. T-Mobile (TMUS) downgraded to Neutral from Buy at MoffettNathanson. 4. AMAG Pharmaceuticals (AMAG) downgraded to Market Perform from Outperform at Leerink and to Neutral from Buy at Janney Capital. 5. BP (BP) downgraded to Market Perform from Outperform at BMO Capital analyst Brendan Warn citing his belief that the company will make a major acquisition this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/06/17
UBSW
01/06/17
NO CHANGE
Target $285
UBSW
Buy
Goldman Sachs price target raised to $285 from $234 at UBS
UBS analyst Brennan Hawken raised his price target on Goldman Sachs $285 from $234 citing its earnings power and expectations for the bank to take market share as the revenue environment improves. Hawken reiterated his Buy rating on Goldman Sachs shares.
12/21/16
12/21/16
DOWNGRADE
Target $240

Neutral
Goldman Sachs downgraded due to valuation at Atlantic Equities
As previously reported, Atlantic Equities downgraded Goldman Sachs to Neutral from Overweight. Analyst Christopher Wheeler said Goldman will be a major beneficiary of a better tone to capital markets post-election but said shares have rallied strongly through his $240 price target.
C Citi
$59.75

-0.485 (-0.81%)

01/09/17
MSCO
01/09/17
NO CHANGE
MSCO
Citi is a Q4 Top Pick at Morgan Stanley
Morgan Stanley analyst Betsy Graseck named Citi as its Large Cap Bank Top Pick into Q4 given stronger FICC and lower expenses. Graseck rates Citi an Overweight with a $70 price target.
01/10/17
STPT
01/10/17
DOWNGRADE
STPT
Hold
Citi downgraded to Hold from Buy at Standpoint Research
01/11/17
UBSW
01/11/17
DOWNGRADE
Target $58
UBSW
Sell
Citi downgraded to Sell from Buy at UBS
UBS analyst Saul Martinez double downgraded Citi to Sell from Buy after assuming coverage of the name. The bank's global footprint leaves it less levered to lower corporate tax rates and higher interest rates in the U.S., and more exposed to risks associated with President-elect Trump's "protectionist" policy stance, Martinez tells investors in a research note. He cut his price target for Citi shares to $58 from $64.
12/21/16
ATLE
12/21/16
UPGRADE
Target $70
ATLE
Overweight
Citi upgraded to Overweight on lower domestic taxes at Atlantic Equities
As previously reported, Atlantic Equities upgraded Citi to Overweight from Neutral with a $70 price target. Analyst Christopher Wheeler said Citi shares have lagged its peer group since the election due to lower relative domestic earnings but said the company will also benefit from lower domestic tax rates and expects shares to "catch up" in 2017.
JPM JPMorgan
$86.55

0.12 (0.14%)

11/11/16
RBCM
11/11/16
NO CHANGE
RBCM
Banks to benefit from higher interest rates, says RBC Capital
RBC Capital believes that the Fed is committed to raising interest rates, and it expects FOMC members' forecast to show they expect two rate increases to occur in 2017. The firm expects higher rates to boost banks' net interest margin, raising their profits. It identifies Bank of America (BAC), JPMorgan (JPM), Citizens Financial (CFG),M&T Bank (MTB), and Regions Financial (RF) as being among the banks most likely to benefit from short-term rate increases.
11/18/16
11/18/16
INITIATION
Target $65

Underweight
American Express initiated with an Underweight at Stephens
As previously reported, Stephens analyst started American Express (AXP) with an Underweight rating and $65 price target, citing rising rates, shrinking markets as American Express ramps up rewards to maintain share, and the risk to 2017 EPS guidance. The analyst expects competition from bank peers, such as JPMorgan (JPM) and Citi (C), to continue to pressure American Express' earnings.

TODAY'S FREE FLY STORIES

VSM

Versum Materials

$37.86

0.16 (0.42%)

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Initiation
Versum Materials initiated  »

Versum Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Syndicate
Juno Therapeutics files $225M automatic stock shelf »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

, BSTI

Best Inc.

16:16
09/20/17
09/20
16:16
09/20/17
16:16
General news
On The Fly: Top stock stories for Wednesday »

Stocks were largely on…

AAPL

Apple

$156.07

-2.66 (-1.68%)

BSTI

Best Inc.

BABA

Alibaba

$177.95

-2.12 (-1.18%)

FDX

FedEx

$220.53

4.531 (2.10%)

ADBE

Adobe

$149.96

-6.64 (-4.24%)

GIS

General Mills

$52.17

-3.215 (-5.81%)

CPRT

Copart

$33.86

1.32 (4.06%)

ALNY

Alnylam

$113.78

38.7408 (51.63%)

IONS

Ionis Pharmaceuticals

$53.88

-5.19 (-8.79%)

BBBY

Bed Bath & Beyond

$22.74

-4.29 (-15.87%)

DESP

Despegar.com

CELC

Celcuity

$14.29

14.289 (1,428,900.00%)

ZLAB

Zai Lab

KRYS

Krystal Biotech

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 22

    Oct

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

APC

Anadarko

$44.78

1.02 (2.33%)

16:15
09/20/17
09/20
16:15
09/20/17
16:15
Hot Stocks
Anadarko reaffirms production guidance »

"Separately, we want…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FCPT

Four Corners Property Trust

$25.32

0.02 (0.08%)

16:14
09/20/17
09/20
16:14
09/20/17
16:14
Hot Stocks
Four Corners Property Trust acquires 41 restaurant properties »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$44.79

1.03 (2.35%)

16:13
09/20/17
09/20
16:13
09/20/17
16:13
Hot Stocks
Anadarko targets $1B of of share repurchases prior to year-end 2017 »

Speaking about the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

, GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

16:12
09/20/17
09/20
16:12
09/20/17
16:12
Hot Stocks
GlaxoSmithKline and Innoviva report positive Phase 3 results of Treleg Ellipta »

Theravance Biopharma…

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

INVA

Innoviva

$13.59

0.08 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 24

    Oct

APC

Anadarko

$44.79

1.025 (2.34%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Anadarko announces $2.5B share repurchase program »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

QUAD

Quad/Graphics

$20.16

0.33 (1.66%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Quad/Graphics awarded $450M contract to print all Bluestem catalogs »

Quad/Graphics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MLHR

Herman Miller

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Herman Miller »

Herman Miller reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

STBZ

State Bank Financial

$27.79

0.45 (1.65%)

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
FDIC approves State Bank Financial, AloStar merger transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Hot Stocks
Herman Miller CEO says 'encouraged by the strong level of demand' »

Brian Walker, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ARCC

Ares Capital

$15.85

0.035 (0.22%)

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Initiation
Ares Capital initiated  »

Ares Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:06
09/20/17
09/20
16:06
09/20/17
16:06
Earnings
Herman Miller sees Q2 EPS 55c-61c, consensus 56c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MLHR

Herman Miller

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Earnings
Herman Miller reports Q1 adjusted EPS 57c, consensus 57c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MDXG

MiMedx

$12.34

-0.82 (-6.23%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
MiMedx responds to two "deceptive short seller articles" »

MiMedx Group responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LUNA

Luna Innovations

$1.64

0.05 (3.14%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
Luna Innovations announces stock repurchase program »

Luna Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03
Hot Stocks
Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02% »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Feb

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.